Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Thomas

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Annals of Clinical and Translational Neurology|May 19, 2025
The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber TypeLong Davalos, Brian C Callaghan, Lavanya Muthukumar, et al.
Frontiers in Immunology|May 18, 2026
Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphomaTim Schlierkamp-Voosen, Markus Barden, Helena Janning, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 20, 2024
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)-a white paperPaola Alberti, Andreas A Argyriou, Jordi Bruna, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 21, 2024
Correction to: Considerations for establishing and maintaining international research collaboration: the example of chemotherapy‑induced peripheral neurotoxicity (CIPN)-a white paperPaola Alberti, Andreas A Argyriou, Jordi Bruna, et al.
Annals of Neurology|April 11, 2026
Homozygous RFC1 AAGGG Repeat Expansions Are Common in Idiopathic Peripheral NeuropathyZitian Tang, Sinem S Ovunc, Ryo Iwase, et al.
Cancers|April 30, 2021
Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous MetaboliteRaffaela S Berger, Christian J Wachsmuth, Magdalena C Waldhier, et al.
Frontiers in Pharmacology|November 20, 2018
Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia CellsKathrin Renner, Anton Seilbeck, Nathalie Kauer, et al.
Journal of the Peripheral Nervous System : JPNS|November 21, 2023
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patientsPerry T C van Doormaal, Simone Thomas, Senda Ajroud-Driss, et al.
Haematologica|October 26, 2023
Low-dose azacitidine, pioglitazone and all-<i>trans</i> retinoic acid is safe in patients aged ≥60 years with acute myeloid leukemia refractory to standard induction chemotherapy (AMLSG 26-16/AML-ViVA): results of the safety run-in phaseDaniel Heudobler, Florian Luke, Joachim Hahn, et al.
Cancers|September 27, 2025
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid NeoplasmsSimone Thomas, Martin Wermke, Vladan Vučinić, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Annals of Clinical and Translational Neurology|May 19, 2025
The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber TypeLong Davalos, Brian C Callaghan, Lavanya Muthukumar, et al.
Frontiers in Immunology|May 18, 2026
Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphomaTim Schlierkamp-Voosen, Markus Barden, Helena Janning, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 20, 2024
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)-a white paperPaola Alberti, Andreas A Argyriou, Jordi Bruna, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 21, 2024
Correction to: Considerations for establishing and maintaining international research collaboration: the example of chemotherapy‑induced peripheral neurotoxicity (CIPN)-a white paperPaola Alberti, Andreas A Argyriou, Jordi Bruna, et al.
Annals of Neurology|April 11, 2026
Homozygous RFC1 AAGGG Repeat Expansions Are Common in Idiopathic Peripheral NeuropathyZitian Tang, Sinem S Ovunc, Ryo Iwase, et al.
Cancers|April 30, 2021
Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous MetaboliteRaffaela S Berger, Christian J Wachsmuth, Magdalena C Waldhier, et al.
Frontiers in Pharmacology|November 20, 2018
Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia CellsKathrin Renner, Anton Seilbeck, Nathalie Kauer, et al.
Journal of the Peripheral Nervous System : JPNS|November 21, 2023
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patientsPerry T C van Doormaal, Simone Thomas, Senda Ajroud-Driss, et al.
Haematologica|October 26, 2023
Low-dose azacitidine, pioglitazone and all-<i>trans</i> retinoic acid is safe in patients aged ≥60 years with acute myeloid leukemia refractory to standard induction chemotherapy (AMLSG 26-16/AML-ViVA): results of the safety run-in phaseDaniel Heudobler, Florian Luke, Joachim Hahn, et al.
Cancers|September 27, 2025
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid NeoplasmsSimone Thomas, Martin Wermke, Vladan Vučinić, et al.
Pageof 7